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Abstract
Dietary non-heme iron contains ferrous [Fe(II)] and ferric [Fe(III)] iron fractions and the latter should hydrolyze,
forming Fe(III) oxo-hydroxide particles, on passing from the acidic stomach to less acidic duodenum. Using
conditions to mimic the in vivo hydrolytic environment we confirmed the formation of nanodisperse fine ferrihydrite-
like particles. Synthetic analogues of these (~ 10 nm hydrodynamic diameter) were readily adherent to the cell
membrane of differentiated Caco-2 cells and internalization was visualized using transmission electron microscopy.
Moreover, Caco-2 exposure to these nanoparticles led to ferritin formation (i.e., iron utilization) by the cells, which,
unlike for soluble forms of iron, was reduced (p=0.02) by inhibition of clathrin-mediated endocytosis. Simulated
lysosomal digestion indicated that the nanoparticles are readily dissolved under mildly acidic conditions with the
lysosomal ligand, citrate. This was confirmed in cell culture as monensin inhibited Caco-2 utilization of iron from this
source in a dose dependent fashion (p<0.05) whilet soluble iron was again unaffected. Our findings reveal the
possibility of an endocytic pathway for acquisition of dietary Fe(III) by the small intestinal epithelium, which would
complement the established DMT-1 pathway for soluble Fe(II).
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Introduction
Dietary non-heme iron (Fe) contains ferrous [Fe(II)] and ferric
[Fe(III)] fractions in a number of chemical forms: for example
Fe in ferritin and in Fe-sulphur cluster proteins [1–3]. Redox
changes to dietary Fe between the points of ingestion and
cellular uptake from the intestinal lumen are complex and may
favour oxidation to Fe(III) due to intestinal pH and endogenous
ligands, or reduction to Fe(II) due to the presence of ascorbate
and low luminal oxygen levels [4,5]. Overall, however, both
Fe(II) and Fe(III) appear to reach the intestinal epithelial
surface to some extent [4,6–8]. Fe(II) is transported by the
divalent metal transporter-1 (DMT-1) and Fe(III) is proposed to
undergo enzymatic reduction to Fe(II), perhaps by duodenal
cytochrome B (DcytB), prior to transport by DMT-1 [9–13].
Chemically, however, there is an uncomfortable paradox with
respect to this latter pathway. Fe(III) is remarkably insoluble at
duodenal pH, immediately precipitating out of solution as Fe(III)
poly oxo-hydroxide:
[logKeq Fe3+  +  3  H2O  u  Fe(OH)3  +  3H+ =  -11.7 [14]].
To obviate iron precipitation several authors have suggested
the presence of endogenous Fe binding agents (i.e. proteins,
organic acids etc.) in gastrointestinal secretions that retain
Fe(III) in a soluble form. The aluminium ion (Al(III)) can be
viewed as a kinetically less labile, non-paramagnetic metal ion
(M) ‘probe’ for Fe(III). Work on the chemical speciation of Al(III)
in the intestinal lumen did not identify any endogenous ligands
that could prevent its precipitation as an oxo-hydroxide at peri-
neutral pH [15]. Instead, Powell et al. proposed that a range of
endogenous, low molecular weight ligands could slow the rate
of hydrolysis to allow M(III) binding to gastrointestinal mucins
[15]. Indeed, luminal Fe binding to gastrointestinal mucins has
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been identified by a number of authors [8,16,17] and so
effective is this binding that gastric mucin has been previously
referred to as ‘gastroferrin’: the endogenous gastro(intestinal)
molecule that can keep dietary Fe(III) in ‘solution’ [18–24].
Rudzki et al. detailed the nature of the binding between Fe(III)
and the Fe-binding glycoprotein of gastric juice (mucin) and
showed that at pH values of the proximal bowel (typical pH
range 5.8-6.7 [25]), Fe(III) is not quite kept in ‘solution’
[26].Instead, it appears that Fe(III) commences hydrolysis but
further growth and agglomeration of the Fe(III) poly oxo-
hydroxide nanoparticles are prevented by mucin binding [26].
They visualized the nanoparticles formed in the Fe-glycoprotein
complex, noting that they were ~10-20 nm in diameter and
appeared to be amorphous aggregates. The Fe(III) oxo-
hydroxide phase expected to first precipitate from an Fe(III)-
bearing solution at proximal small bowel pH is ferrihydrite [27].
This is a cross-linked polymeric (i.e. poorly (nano)crystalline)
phase with primary platelets of 2-5 nm in size depending on the
degree of crystallinity and is prone to agglomeration and
aggregation [28]. Rudzki et al. produced a synthetic version,
referring to this phase as colloidal Fe and, importantly, showed
that direct instillation of this ferrihydrite–mucin solution into the
duodenum of rats, led to Fe absorption nearly equivalent to that
of the gold standard, Fe(II) ascorbate [26].
How nanoparticulate Fe(III) poly oxo-hydroxide, which is
insoluble at duodenal pH, would be acquired by enterocytes
and processed for absorption and utilization is not clear.
Current understanding of dietary Fe(III) absorption suggests
synergistic association between an intestinal ferrireductase
(e.g. DcytB) and the apical Fe(II) transporter ( DMT-1) such
that the enzyme reduces Fe(III) allowing its transport and
absorption. However, our current in vivo studies reasonably
preclude the requirement for reduction and dissolution of Fe(III)
poly oxo-hydroxide prior to uptake by the enterocyte (Pereira,
Latunde-Dada and Powell; unpublished observations). To
investigate the above paradox in more detail we first built on
the model of Rudzki et al. [26,29] using mucin plus typical low
molecular weight ligands of the gastrointestinal lumen to better
mimic in vivo Fe(III) hydrolysis. We confirmed the formation of
a fine ferrihydrite-like phase in ‘luminally hydrolysed’ dietary
Fe(III) and then we probed cellular uptake and utilization of
synthetic ligand-modified ferrihydrite, as an analogue for this
nanoparticulate phase, demonstrating the requirement of
endocytic uptake mechanisms.
Materials and Methods
Synthesis of iron materials
Soluble Fe(II) material was prepared by mixing an acidified
stock solution of Fe(II) sulphate heptahydrate (40 mM) with a
stock solution of ascorbic acid (0.5 M) to achieve a molar ratio
of 1:100 (Fe:ascorbic acid). Soluble Fe(III) maltol chelate
(Fe(III) maltol) was produced by mixing a stock solution of
Fe(III) chloride (8 mM) with a maltol (3-hydroxy-2-methyl-4H-
pyran-4-one) solution (40 mM) to achieve a molar ratio of
Fe:maltol of 1:5. Soluble Fe(III) nitrilotriacetate chelate (Fe(III)
NTA) was produced by mixing a solution of Fe(III) chloride (8
mM) with a NTA solution to achieve a molar ratio of Fe:NTA of
1:5. The pH of the above mixtures was adjusted to 7.4 with
NaOH prior to use. Ligand-modified (LM) Fe(III) poly oxo-
hydroxide material was produced following the protocol
described by Powell et al. [30]. Briefly, an acidic concentrated
stock solution of Fe(III) chloride (40 mM) was added to a
solution containing tartaric acid and adipic acid or, in the case
of un-modified Fe(III) oxo-hydroxide, to 0.9 %(w/v) of
electrolyte (potassium chloride). The initial pH of the mixture
was always below 2.0 and the iron was fully solubilized. The
pH was then slowly increased by drop-wise addition of a
concentrated solution of NaOH with constant agitation until the
desired final pH (ca. 7.4 for LM Fe(III) poly oxo-hydroxide and
7.4-8.2 for un-modified Fe(III) oxo-hydroxide) were attained. In
the case of LM Fe(III) poly oxo-hydroxide the ratio of Fe:tartaric
acid:adipic acid in the final suspension was 2:1:1.
Chemical characterisation
Detailed methods of the below are provided in the
Supplementary Methods S1. Fe(III) structures were
characterised by transmission electron microscopy (TEM) after
hydrolysis of Fe(III) in simulated digestion medium. The
solubility of LM Fe(III) poly oxo-hydroxide and un-modified
Fe(III) poly oxo-hydroxide (i.e. standard synthetic ferrihydrite)
was determined at pH 5.0 ± 0.1 in a 10 mM citric acid, 0.15 M
NaCl solution. The Fe material was added to the assay solution
at an Fe concentration of ca. 1 mM and incubated for 360 min
at room temperature. Soluble iron was determined following
ultrafiltration (3,000 Da MWCO). The hydrodynamic particle
size of the nanoparticulate LM Fe(III) poly oxo-hydroxide
material was determined by Dynamic Light Scattering (DLS)
and the non-aquated primary particle size by Transmission
Electron Microscopy (TEM).
Cellular uptake studies
To avoid aggregation/agglomeration of the nanoparticulate
iron, the medium for cellular uptake consisted of a balanced
salt solution (BSS) containing 130 mM NaCl, 10 mM KCl, 1 mM
MgSO4, 5 mM Glucose and 1 mM CaCl2 in 10 mM PIPES
buffer (pH 7.4). Immediately before the cellular uptake
experiments, fresh solutions of the Fe materials were prepared
in BSS at an Fe concentration of 200 たM and the partition of
the Fe into the soluble, nanoparticulate and microparticulate
fractions was assessed to assure that most of the Fe (i.e.
>90%) was present in the nanoparticulate fraction and had not
agglomerated/aggregated. DLS measurements were also
taken of the nanoparticulate fraction to assure a mono-disperse
distribution of the intended size (i.e. ~10nm). Detailed
methodology is shown in Methods S1.
Iron uptake in undifferentiated Caco-2 cells
Human adenocarcinoma (Caco-2) cells were obtained from
ATCC (LGC standards, Middlesex, United Kingdom). Cells
were seeded at 1.13 x 106 cells/mL onto 6-well cell culture
plates. Plates were centrifuged at 680 xg for 5 min to remove
the growth medium. The different Fe preparations in uptake
medium were carefully added to the cells and incubated for 1 h
at 37° C. Uptake medium with no supplemented Fe was also
incubated with cells as a control. Each condition was tested in
Dietary Iron(III) Uptake Invokes Endocytosis
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triplicate wells for each experiment. After the Fe incubation
period, the uptake medium was removed by centrifugation and
aspiration, and the cells were washed with phosphate buffered
saline (PBS)-EDTA (2 mM) to remove any loosely bound Fe.
The cells were then resuspended in fresh MEM (with no
supplemental Fe) and returned to the incubator for an
additional 23 h to allow for ferritin-protein formation to plateau
[31]. At the end of the incubation period, the cells were washed
with Dulbecco's Phosphate-Buffered Saline (DPBS; PAA
Laboratories) and lysed with Mammalian Protein Extraction
Reagent (MPER®, Thermo Fisher Scientific, Cramlington, UK).
After lysis, cell debris was removed by centrifugation (5 min,
16,000 xg) and the supernatant used for analysis.
Iron uptake in differentiated Caco-2 cells
Cells (Caco-2 ATCC as above) were seeded at ca. 1.8 x 105
cells/mL onto 6-well cell culture plates. The Caco-2 cells were
maintained under the culture conditions described in Methods
S1 and used for the Fe uptake experiments at 11 or 12 days
post-seeding. Cell differentiation and formation of a cell
monolayer were confirmed for this timepoint as described in
Methods S1. Approximately 16 h prior to the experiments the
growth medium was replaced by non-supplemented MEM, i.e.
without FBS or antibiotics, and cells were returned to the
incubator. This was carried out to ‘starve’ cells of Fe prior to the
experiments and did not induce any changes in the cell
monolayer integrity as confirmed by TEER measurements. The
Caco-2 cell monolayer was then washed once with pre-warmed
DPBS and incubated with the different Fe materials or control
uptake medium for 1 h at 37° C. For each experiment every
condition was investigated in triplicate wells. Following the Fe
incubation period the uptake medium was removed, the cell
monolayer was washed three times with PBS-EDTA (2 mM) to
remove any Fe loosely adherent to the cell membrane and
fresh non-supplemented MEM was added. The cells were then
returned to the incubator for an additional 23 h to allow for
ferritin-protein formation [31]. At the end of the incubation
period, the cells were washed and lysed as before. The cell
lysate supernatant was used for analysis.
The Caco-2 cells requirement of energy for Fe uptake from
Fe(III) maltol or the nanoparticulate LM Fe(III) poly oxo-
hydroxide was investigated by low temperature incubation. The
cells were kept on ice for 10 min prior to the experiment and
during the 1 h incubation period with the two Fe materials
suspended in uptake medium. The cells were then washed 3
times with ice-cold PBS-EDTA (2 mM) and fresh non-
supplemented MEM was added and the cells incubated for the
remaining 23 h at 37° C and treated as above.
To study the effect of endocytosis-related-pathway-inhibitors
on Fe uptake from the different materials, Caco-2 cells were
co-incubated for 1 h at 37° C with the Fe materials in BSS
supplemented with the following inhibitors (each inhibitor tested
in triplicate wells): chlorpromazine (100 µM), filipin (5 mg/L),
methyl-く-cyclodextrin (5 mM). Additionally, cells were
incubated with Fe in K+-free BSS consisting of 130 mM NaCl, 1
mM MgSO4, 5 mM glucose and 1 mM CaCl2 in 10 mM PIPES
buffer (pH 7.4). For this experimental condition cells were pre-
incubated for 5 min with a 1:1 mixture of Dulbecco's Modified
Eagle Medium (DMEM):water prior to incubation in K+-free
medium. For the cellular lysosomal dissolution experiments,
cells were co-incubated for 1 h at 37° C with the Fe materials in
BSS supplemented with monensin (5-30 µM). As before ferritin-
formation was assessed at 23h following the removal of the
inhibitors and Fe materials. Controls were performed for each
inhibitor by incubating the cells with uptake medium (BSS)
supplemented with the inhibitor but not containing Fe.
Chlorpromazine [32,33] and K+ free BSS [33,34] were used
to inhibit clathrin-mediated uptake. Filipin [35] and methyl-く-
cyclodextrin [34,36] were used to inhibit caveolin-mediated
uptake. Monensin was used to inhibit acidification of
endosomes/lysosomes [37–39].
Analysis
Cell lysate supernatants were analysed for cellular ferritin-
protein content using the commercial enzyme-linked
immunosorbent assay kit “Spectro Ferritin” (ATI Atlas,
Chichester, UK). The uptake data were normalized to total cell
protein content determined with the non-interfering protein
assay™ (NIPA™, Calbiochem/Merck, Nottingham, UK). TEER
measurements were carried out to determine if the chemical
inhibitors used in the uptake studies had a negative impact on
the integrity of the cell monolayer (an early indication of
toxicity) as detailed in Methods S1. Electron microscopy was
used to visualize nanoparticulate Fe uptake by the Caco-2 cells
as detailed in Methods S1.
Statistical analysis
All statistical analysis was performed using GraphPad Prism
version 6 for Windows (GraphPad Software, San Diego,
California, USA). Unless stated otherwise, results are
presented as means with standard deviations (s.d.). The
unpaired t-test was used to statistically compare ferritin-protein
formation for the different Fe compounds in differentiated and
undifferentiated cells and ferritin-protein formation with and
without chemical inhibitors of endocytosis-related pathways
(level of significance set to p<0.05). The repeated measures 2-
way ANOVA with Sidak correction for multiple comparisons
was used to statistically compare TEER at different time points.
Regular 2-way ANOVA (no matching) was used to statistically
compare ferritin formation for different monensin doses
between the nano Fe and the soluble Fe materials. Ferritin-
protein concentration in the presence of monensin was fitted
with a non-linear dose-response inhibition curve (i.e.
Log10(inhibitor) versus response).
Results and Discussion
Formation and cellular uptake of ligand-modified Fe(III)
poly oxo-hydroxide nanoparticles
First, as a mimetic of gastrointestinal hydrolysis conditions,
Fe(III) chloride was dissolved at pH 1.2 in a solution of
relevant, low molecular weight ligands and gastric porcine
mucin and then adjusted to pH 6.5-7.1 using sodium
bicarbonate (final Fe concentration 1 mM) (detailed
methodology is available in Methods S1). A drop of the
Dietary Iron(III) Uptake Invokes Endocytosis
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resultant ‘solution’ (colloidal suspension) was placed on a thin
amorphous carbon film for TEM and imaged. Agglomerates of
fine (~5 nm) poorly crystalline particles in an amorphous gel
were noted (Figure 1A). Whole area energy dispersive X-ray
spectroscopy (EDX) showed these to be Fe-containing (Figure
1B), and electron diffraction (not shown) indicated a mixture of
two phases – ferrihydrite-like (two broad diffraction rings
characteristic of 2-line ferrihydrite [40]) and a second phase
which was not uniquely identified (two broad diffraction rings at
0.20 and 0.13 nm). Under prolonged exposure to the electron
beam the particles agglomerated further, developed in
crystallinity and the diffraction pattern became dominated by
this second phase: it was still not possible to confirm the
identity of this alteration product but an Fe phosphate
hydroxide provides the closest match to the observed lattice
spacings (International Centre for Diffraction Data powder
diffraction file 00-047-0413). Irradiation damage to poorly
crystalline fine particles such as ferrihydrite [41] is well
recognized, especially in the absence of supporting resin or
tissue structure, so we considered this second phase to be
artifactual. Hence the larger particles (10-20 nm) observed in
the earlier work of Rudzki et al. [26] are, likely, an artifact of
beam damage but the smaller particles are not. Moreover, the
hydrolysis of the Fe(III) and the formation of these fine,
disperse, ferrihydrite-like particles was not prevented by the
presence of typical gastrointestinal low-molecular weight
ligands. As a simplified and practical analogue to the above
ferrihydrite-like particles we have developed ligand-modified
(LM) Fe(III) poly oxo-hydroxides of similar size and structure
[30]. This ligand-modified analogue remains well-dispersed
upon aqueous suspension in the uptake medium used for
cellular experiments (balanced salt solution: BSS) taking on an
average hydrodynamic particle diameter of 10 nm (Figure 1C).
Here, ferritin-protein formation of epithelial cell cultures, as a
measure of cellular iron utilisation, was assessed following a 24
h total incubation period that involved 1 h Fe exposure of cells
in BSS followed by washing, change of medium, and a 23 h
incubation in non-supplemented minimum essential medium
(MEM) (i.e. with very low Fe content). We used soluble Fe,
either as Fe(III) maltol [42] or Fe(II) sulphate-ascorbate as
positive controls [31]. Initially, we used both differentiated and
undifferentiated cells and iron utilization varied greatly for the
LM Fe(III) poly oxo-hydroxide structures (undifferentiated >
differentiated; p=0.0003) but not at all for the soluble Fe(III)
(Figure 2A). Alkaline phosphatase levels were used as a
marker for Caco-2 cell differentiation and the integrity of the cell
monolayer was assured prior to the experiments (see Figure
S1). The solid phase distribution, i.e. the partition of the Fe in
the soluble, nanoparticulate (aquated) or microparticulate
(agglomerated) fractions, largely confirmed the nanoparticulate
nature of the LM Fe(III) poly oxo-hydroxide and the solubility of
the Fe(III) maltol and Fe(II) sulphate-ascorbate (Figure 2B).
Cellular uptake and utilization of the LM Fe(III) poly oxo-
hydroxide required nano dispersion because purposeful
agglomeration to microparticles (first hour in MEM, rather than
in BSS, leading to 97 ± 2% microparticulate iron at 30 min)
prevented iron utilization (Figure 2C). We confirmed that BSS
did not affect monolayer integrity for the duration of the
exposure (Figure 2D) although Fe(II) sulphate-ascorbate did
[31], so further cellular work used Fe(III) maltol as the soluble
control.
Hence, the uptake and utilization of LM Fe(III) poly oxo-
hydroxide required its dispersion in nanoparticulate form
(Figure 2C) and the mechanism of acquisition appeared
different to that of soluble Fe (Figure 2a). Next we investigated
energy requirements for Fe uptake by comparing data at 37° C
with those at low temperature (i.e. on ice). Fe utilization from
Fe(III) maltol at low temperature was decreased by 95 % (95 ±
1; n=3) as expected, but from nanoparticulate LM Fe(III) poly
oxo-hydroxide the reduction was only ca. 20 % (19 ± 13; n=3)
(Figure S2). Apparent low temperature uptake of nanoparticles
has been observed before [43,44] and is attributed to particle
adhesion to the cell membrane. Adherent particles, that
withstand washing, may be subsequently taken up by cells
(and in this case utilized to form ferritin-protein, indicating that
cells remained healthy) upon re-incubation in fresh medium at
37° C. Electron microscopy indicated cell surface adhesion of
the nanoparticles and also showed that, generally, the cell
membrane tended to induce loose agglomeration or
aggregation of the particles into clusters up to 200 nm in
diameter (Figure 3A). Thus we considered that Fe from the LM
Fe(III) poly oxo-hydroxide nanoparticles was utilized following
acquisition by endocytic uptake, as this is superior in
undifferentiated versus differentiated Caco-2 cells [45], and cell
surface adhesion is a requirement prior to uptake. Indeed
further electron microscopy work revealed evidence of cell
surface invagination (Figure 3B) with respect to the surface
clusters of LM Fe(III) poly oxo-hydroxide and showed loose
agglomerates of ≤ 200 nm in diameter within vesicles that we
suggest are endosomes or lysosomes (Figure 3C, D). TEM
images were also collected for control Caco-2 cells: i.e. cells
incubated with non-supplemented BSS and cells incubated
with BSS supplemented with the soluble Fe(III) maltol chelate
and no discernible particulate Fe was observed (Figure S3). To
determine whether nanoparticulate uptake contributed to
cellular Fe utilization of the LM Fe(III) poly oxo-hydroxide we
used an inhibitor of clathrin-mediated endocytosis, namely
chlorpromazine, at a dose of 100 たM consistent with previous
studies [32,33]. We confirmed that this significantly reduced
(p=0.02) ferritin-protein formation in the cells exposed to LM
Fe(III) poly oxo-hydroxide (Figure 3E), without significantly
affecting monolayer integrity (Figure 3F), whilst no difference
was observed for soluble iron uptake (Figure 3E, F). Further
endocytic-inhibition studies with K+ depletion, filipin and methyl-
く-cyclodextrin suggested the same picture: namely that Fe
utilization appeared reduced albeit so only for LM Fe(III) poly
oxo-hydroxide exposure and not for soluble Fe (Figure 3D).
Interestingly, filipin and methyl-く-cyclodextrin inhibit caveolae-
related rather than clathrin-mediated endocytosis so, consistent
with previous nanoparticulate uptake work, there either
appears to be a degree of redundancy/overlap between the
uptake pathways [43] or precise uptake may be related to the
size range of the nanoparticulate clusters formed on the cell
membrane [46–49]. All cell monolayers appeared healthy
under the microscope, and also without significant changes in
TEER measurements, under the assay conditions used with K
Dietary Iron(III) Uptake Invokes Endocytosis
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+-free BSS and methyl-く-cyclodextrin (Figure 3F), although no
TEER assessment was made with filipin.
Lysosomal dissolution of ligand-modified Fe(III) poly
oxo-hydroxide nanoparticles enables cellular utilization
of iron
Overall, direct endocytosis of LM Fe(III) poly oxo-hydroxide
nanoparticles by differentiated Caco-2 cells appears, chiefly, to
explain uptake of Fe under these conditions. However, this Fe
still needs to be released for cellular utilization (i.e. ferritin-
protein synthesis in the current cell assay) and there would be
insufficient intracellular (lysosomal) acidification for this alone
to drive the release and cytosolic iron transit. Skotland et al.
[50] developed a simplified endosomal/lysosomal solution that
included 10 mM citrate and this chelator might, when aided by
endosomal/lysosomal acidification, enable the breakdown and
release of Fe from these fine, ligand-destabilized ferrihydrite-
like particles. We showed that under these simplified
endosomal/lysosomal conditions soluble Fe could be released
Figure 1.  Characterisation of hydrolysed Fe(III) with simulated digestion and of aquated LM Fe(III) poly oxo-hydroxide.  A,
Transmission Electron Microscopy (TEM) images collected from a drop of suspension after simulated digestion of 1 mM Fe(III)
chloride in the presence of 2 g/L mucin and low molecular weight ligands. The boxed regions are shown magnified below and
highlight the presence of fine, poorly crystalline nanoparticles dispersed in an amorphous gel. Crystallinity is indicated by the spots
in the inset diffractograms (fast Fourier transforms) in the boxed regions and lattice spacings are discussed in the main text. Scale
bar represents 5 nm. B, Whole area EDX analysis of a particle agglomerate similar to those in ‘A’ shows elemental compositions
(the specimen support film and grid produce the background C and Cu signals respectively). C, Hydrodynamic size distribution of
nanoparticulate 500 µM LM Fe(III) poly oxo-hydroxide in balanced salt solution (BSS) measured by Dynamic Light Scattering (DLS).
Values are expressed as mean diameter ± s.d. (3 independent measurements) on a log10 scale.
doi: 10.1371/journal.pone.0081250.g001
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Figure 2.  Ferritin-protein levels in Caco-2 cells following exposure to LM Fe(III) poly oxo-hydroxide (nano Fe), Fe(III) maltol
(FeM) or Fe(II) sulphate-ascorbate (FeSO4 + AA).  A, Ferritin-protein regulation in differentiated and undifferentiated cells. ***,
p=0.0003. Cells were incubated for 1 h with 200 たM Fe plus a further 23 h in fresh, non-supplemented MEM to allow for ferritin
formation. B, Phase distribution of Fe in the BSS uptake medium: i.e. fractional percentage of microparticulate (black bars),
nanoparticulate (red bars) and soluble Fe (open bars) for each Fe material. Values are mean ± s.d. of 3 independent experiments.
C, Effect of LM Fe(III) poly oxo-hydroxide particle dispersion (in BSS medium, closed bars) or agglomeration (in MEM medium,
open bars) on ferritin-protein levels in differentiated cells: the LM Fe(III) poly oxo-hydroxide was dispersed in its nano-form (99 ± 2%
nano) using BSS or agglomerated (97 ± 2% microparticulate) using MEM. Data are mean of 3 independent experiments (each
experiment with 3 replicate wells). FeM: soluble iron control, Fe(III) maltol. ***, p=0.0002 for the comparison between BSS and
MEM. D, TEER changes in differentiated Caco-2 cell monolayer at different time points during incubation with BSS supplemented
with LM Fe(III) poly oxo-hydroxide (open circles) or non-supplemented BSS control (closed inverted triangles). Incubations were for
3 h with 200 たM Fe (measurements at 1, 2 & 3 h) plus a further 21 h in fresh, non-supplemented MEM (24-h). Values are expressed
as a percentage of the initial measurement and are shown as mean ± s.d. of 3 independent experiments (each experiment with 3
replicate wells). Experimental points are connected with a solid line to aid visualization and not because a linear relationship is
assumed between time and TEER measurement. Detailed methodology is available in the Methods Section and in Methods S1.
doi: 10.1371/journal.pone.0081250.g002
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Figure 3.  Cellular uptake of nanoparticulate LM Fe(III) poly oxo-hydroxide by Caco-2 cells.  A, B, C, D TEM images showing
differentiated Caco-2 cells incubated with LM Fe(III) poly oxo-hydroxide. A, arrows show particle clusters adhering to the cell
membrane microvilli (scale bar, 500 nm). B, arrows indicate invagination on the cell membrane (scale bar, 100 nm). C and D,
arrows indicate Fe accumulation inside the cell (scale bars: panel C, 500 nm and panel D, 100 nm). E, Effect of chemical inhibitors
of endocytosis-related pathways on Fe utilization by differentiated Caco-2 cells. Data are shown as a percentage of the controls
(without inhibitor) after a 1 h exposure to LM Fe(III) poly oxo-hydroxide (black bars) or Fe(III) maltol (open bars) co-incubated with
either chlorpromazine (CPZ), potassium-free BSS (K+ depletion), filipin or methyl-く-cyclodextrin (M-く-c), plus 23 h in fresh non-
supplemented MEM. Results are mean ± s.d. of 3 independent experiments with 3 replicate wells per experiment for chlorpromazine
(*, p=0.02 relative to control) or triplicate wells of the same experiment for the remaining inhibitors. F, Change in TEER in the
Caco-2 cell monolayer following a 1 h exposure to chlorpromazine (closed diamonds), K+-free BSS (open triangles), M-く-c (open
squares) or non-supplemented BSS (closed inverted triangles) and with 23 h further incubation in fresh MEM (24 h total). Values are
a percentage of the initial measurement (0 h) and are shown as mean ± s.d. as above. Experimental points are connected with a
solid line to aid visualization and not because a linear relationship is assumed between time and TEER measurement. Detailed
methodology is available in the Methods Section and in Methods S1.
doi: 10.1371/journal.pone.0081250.g003
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within hours from the LM Fe(III) poly oxo-hydroxide
(ferrihydrite) structures at pH 5.0 (Figure 4A) whereas, in the
absence of ligand modification, the native Fe(III) poly oxo-
hydroxide was poorly broken down and little soluble Fe was
released (Figure 4A). This ‘destabilization’ role of low molecular
weight ligands in the nano-structured Fe(III) poly oxo-hydroxide
indicates a more likely physiological role for them in the gut
lumen rather than, as originally proposed [19], as donors of
Fe(III) to mucin. Next, using cell studies and monensin to inhibit
endosomal/lysosomal acidification [39], we showed a
monensin-dose-dependent reduction (i.e. Log10 [monensin]
versus [ferritin-protein], r2=0.935, p<0.05) in Fe utilization by
differentiated Caco-2 cells when exposed to LM Fe(III) poly
oxo-hydroxide (Figure 4B), with statistically significant inhibition
of ferritin formation at monensin doses ≥ 7.5 µM (p=0.002).
Again, soluble Fe was unaffected. The monensin doses used
here were equivalent to those reported previously in inhibition
studies of endosomal/lysosomal acidification in Caco-2 cells
[51,52] or other cell types [53,54], even though by 24 h some
disruption of the monolayer was visible by TEER
measurements particularly at the highest monensin dose
(Figure 4C). Nonetheless, the monolayer was intact during the
1 hour cell exposure to Fe (Figure 4C) and, when examined
microscopically, the cell monolayers appeared integral and
healthy at doses of monensin up to 10 µM which still greatly
inhibited ferritin-protein formation (Figure 4B), and there were
similar protein levels in the presence and absence of the
inhibitor (Figure S4).
Finally, we confirmed that none of the inhibitors caused
significant agglomeration of the nanoparticles in the
supplemented uptake medium (Table S1).
Overall Discussion
The Caco-2 cell line has been extensively used for iron
uptake studies [55–59] as following confluence it differentiates
into a polarised cell monolayer that exhibits a phenotype similar
to human small intestinal enterocytes [60,61].
Our data suggest that an endocytic, apical uptake
mechanism exists in these differentiated Caco-2 cells for
uptake of luminally hydrolysed (poly oxo-hydroxide) dietary
Fe(III). This route apparently relies on endocytic uptake of
small clusters of LM Fe(III) poly oxo-hydroxide nanoparticles
which agglomerate at the cell membrane. Many cellular studies
on nanoparticulate uptake and processing are challenged with
issues of agglomeration and aggregation meaning that, finally,
cells are exposed to micron-sized clusters which will be
acquired and processed differently compared to genuinely
disperse nanostructures [46,62,63]. Thus we paid considerable
attention to developing a cell culture medium that mitigated
against such pitfalls and retained appropriate dispersion of the
particles prior to cell delivery [31]. The finding that these fine
LM Fe(III) poly oxo-hydroxide nanoparticles then tend to
agglomerate at the cell membrane must be interpreted with
caution. It could be that the processing required to produce thin
sections for electron microscopy induced clustering. However,
small agglomerates of nanoparticles were observed in
endosomal/lysosomal compartments within the cell and, so, the
Figure 4.  Lysososmal dissolution of LM Fe(III) poly oxo-
hydroxide.  A, Solubility in simulated lysosomal conditions at
pH 5.0 with 10 mM citric acid and 0.15 M NaCl. Soluble Fe was
measured by ICP-OES following 5 min ultrafiltration (3000 Da
MWCO) for the LM Fe(III) poly oxo-hydroxide (black) and for
un-modified Fe(III) poly oxo-hydroxide (solid blue).
Nanoparticulate Fe was obtained from the Fe in the
supernatant following centrifugation excluding the soluble
(ultrafilterable) Fe, and is shown for LM Fe(III) poly oxo-
hydroxide (red) and for un-modified Fe(III) poly oxo-hydroxide
(dotted blue). Values are plotted as mean ± s.d. of 3
independent experiments (each experiment with 3 replicates).
B, Effect of inhibition of lysosomal acidification using monensin
on Fe utilization by differentiated Caco-2 cells. Data are shown
as a percentage of the control (without monensin) at 24 h: i.e. 1
h exposure to 200 µM nanoparticulate LM Fe(III) poly oxo-
hydroxide (open circles) or Fe(III) maltol (closed squares) ±
5-30 µM monensin followed by 23 h in non-supplemented
MEM. Results are means ± s.d. of 3 independent experiments
(each experiment with 3 replicate wells). **, p<0.005; ***,
p<0.001 in relation to the soluble Fe control (Fe(III)maltol). C,
Change in TEER in the Caco-2 cell monolayer following 1 h
exposure to 10 たM monensin (closed squares), 30 たM
monensin (open diamonds) or non-supplemented BSS control
(closed inverted triangles) and with 23 h further incubation in
fresh MEM (24 h in total). Values are expressed as a
percentage of the initial measurement at the start of the
exposure time (corresponding to 0 h) and are shown as mean
± s.d. of 2 independent experiments (each experiment with 3
replicate wells). Experimental points are connected with a solid
line to aid visualization and not because a linear relationship is
assumed between time and TEER measurement. ***,
p=0.0003; ****, p<0.0001 in relation to the non-supplemented
BSS control.
doi: 10.1371/journal.pone.0081250.g004
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particles must have been taken up either as individual particles
or clusters. Moreover, and importantly, we observed loose
clusters almost always smaller than 200 nm diameter and it is
at around this size that uptake mechanisms may switch
between classical endocytosis and macropinocytosis [46,64].
There appears to be no mechanism of macropinocytosis in
intestinal enterocytes, including differentiated Caco-2 cells, and
phagocytosis has been rarely demonstrated [65,66]. The
inhibitors used here were classical endocytic inhibitors and our
findings suggest endocytosis of individual particles or
membrane-induced small clusters. We accept that the
specificity of K+-depletion to clathrin-mediated endocytosis and
methyl-く-cyclodextrin to caveolin-dependent endocytosis in
HuTu cells has been previously questioned [34]. However,
chlorpromazine has been consistently shown to be highly
specific for clathrin-mediated endocytosis in both HuTu and
Caco-2 cells, providing comparable inhibition rates to siRNA
approaches [34,67]. Filipin also appears specific to caveolin-
dependent endocytosis [35,68]. Nonetheless, we do not, here,
suggest dominance of one specific form of endocytosis for the
uptake of LM Fe(III) poly oxo-hydroxide nanoparticles as
further work may be required to conclude on this.
Our observations on Fe utilization by Caco-2 cells, through
endocytic uptake and lysosomal dissolution of nanoparticulate
LM Fe(III) poly oxo-hydroxide, are still consistent with the
established fact that DMT-1 is indispensable for mammalian Fe
absorption and, therefore, survival [69]. DMT-1, as well as
being the enterocyte Fe(II) apical transporter is probably also
the export transporter of the lysosomal membrane [70–72]: i.e.
the point from where endocytosed and then solubilized
nanoparticulate Fe would join the common Fe pool. The
elegant study of Gunshin et al. [69], utilizing an intestinal-
specific DMT-1 knock-out model termed Slc11a2int/int (which is a
cross of Slc11a2flox/flox mice with mice carrying a Villin-Cre
transgene), proved essentiality of this transporter for intestinal
non-haem iron absorption after birth [69]. However, the
Slc11a2int/int model has DMT1 knocked-out in the entire
enterocyte and not solely from the apical membrane [69] and,
therefore, this study did not eliminate DMT-1 functionality in
both apical uptake and cytosolic processing of intracellular
iron.A further point is that laboratory rodent diets poorly
represent the human diet. Invariably the laboratory diet is rich
in fibrous carbohydrate that is poorly digestible in the upper
gastrointestinal tract and will bind Fe(III) thereby preventing
mucosal access. Thus, Fe(II) sulphate is commonly
supplemented into rodent laboratory chow, as for example in
the RMH 3000 LabDiet (PMI Nutrition International) used by
Gunshin et al. in the study referred to above [69]. In this case,
the essentiality of an Fe(II) transporter would be favoured.
Future in vivo rodent experiments could use a diet
representing the more varied human diet for non-heme Fe
(e.g., mixed Fe(II)-Fe(III) salts that undergo gastric dissolution,
plus ferritin-protein) and then establish, in the Slc11a2int/int
mouse, whether or not there is enterocyte lysosomal
accumulation of Fe (i.e. initial apical uptake due to a non
DMT-1 pathway for the hydrolysed Fe(III) and possibly ferritin-
protein fractions, but accumulation due to export failure with
lack of lysosomal DMT-1). Such a diet fed to Slc11a2int/int mice
will delineate the essential role of DMT-1 for apical iron uptake
versus lysosomal iron efflux. Indeed, Kalgaonkar and
Lonnerdal [3] have speculated that dietary ferritin Fe, which
contains subunits of ferrihydrite similar in structure to the LM
Fe(III) poly oxo-hydroxide nanoparticles used herein [73], may
not all be dissolved under post-prandial gastric conditions, and
could be absorbed whole by duodenal enterocytes and
subsequently broken down intra-lysosomally. Moreover,
elsewhere in mammalian Fe physiology, the lysosome is a safe
reservoir for catabolism of Fe-rich species, whether it be
ferritin-protein, red blood cells or transferrin turnover [71,74].
Free Fe is potentially redox active and thus toxic to cells. So
the concept that cells lining the gut are protected from redox
damage (Fe(III) u Fe(II) + e-) due to luminal nanoparticulate
LM Fe(III) poly oxo-hydroxide formation, which is only available
for breakdown in the safest compartment of the cell, i.e. the
endosome/lysosome, is consistent with other aspects of Fe
metabolism. Finally, of particular note, is a paper by Theil and
colleagues [75], published during preparation of this
manuscript, where they show that the Fe derived from dietary
ferritin-protein (i.e. protein-encapsulated ferrihydrite-like
nanostructures) is absorbed differently in rats and humans to
that of DMT-1-dependent Fe(II). Moreover, their findings invoke
an epithelial endocytic process, which we believe we detail
here: i.e. the fraction of dietary iron derived from ferritin-protein
ingestion could lose its protein shell but maintain its ferrihydrite-
like structure following gastrointestinal digestion and ‘ride’ the
endocytic mechanisms that exists for endogenously formed LM
Fe(III) poly oxo-hydroxide. Ultimately, the two forms may look
very similar, being 2-5 nm diameter, destabilized ferrihydrite
[73] and thus, readily solubilized by the enterocyte endosome/
lysosome.
Our preliminary data in duodenal epithelial cells (HuTu-80
cell line) using siRNA targeting DMT1 further supports a
pathway independent of DMT1 and Dcyt B for the intestinal
uptake of LM Fe(III) poly oxo-hydroxide and, thus, not involving
reduction of Fe(III) to Fe(II) (Figure S5).
We have demonstrated the existence of a nanoparticulate
ferrihydrite-like phase in a model of luminally hydrolysed Fe(III)
and, using a synthetic nanoparticulate ligand-modified
ferrihydrite as an analogue, we have shown the existence of an
endocytic pathway of Fe uptake by Caco-2 cells, a gut
epithelial cell model, followed by lysosomal dissolution of
nanoparticulate LM Fe(III) poly oxo-hydroxide which is
consistent with in vivo observations elsewhere [75].
These in vitro mechanistic findings now need to be replicated
by in vivo data for physiological relevance, and, it is noteworthy
that, when supplemented into the diet of iron deficient rats,
these LM Fe(III) poly oxo-hydroxide structures improved
haemoglobin levels in line with Fe(II) sulphate supplementation
[Pereira, Latunde-Dada and Powell unpublished observations].
Supporting Information
Methods S1.  (DOCX)
Table S1.  Iron solid-phase distribution of 200 µM Fe as LM
Fe(III) poly oxo-hydroxide (nano Fe) and Fe(III) maltol
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(FeM) co-incubated with different chemical inhibitors in the
BSS uptake medium.
(DOCX)
Figure S1.  Caco-2 cell growth and differentiation
parameters in monolayers grown for 21 days. A, cell protein
(open circles) and transepithelial electrical resistance (TEER,
closed squares). Data shown are mean ± s.d. of n=3
independent experiments (each experiment with 12 replicate
wells). B, alkaline phosphatase activity (closed triangles). Data
shown are mean ± s.d. of n=3 independent experiments (each
experiment with 3 replicate wells). Under these culture
conditions the cell monolayer is fully confluent at day 5 post-
seeding and differentiated at day 10 post-seeding in
accordance with reference values reported in the literature
[76,77]. .
(TIF)
Figure S2.  Effect of low temperature incubation on ferritin-
protein levels in Caco-2 cells following exposure to LM
Fe(III) poly oxo-hydroxide (nano Fe) or Fe(III) maltol (FeM).
Cells were incubated for 1 h in BSS at 37°C (closed bars) or
4°C (open bars) supplemented with 200 µM Fe plus a further
23 h in fresh, non-supplemented MEM to allow for ferritin
formation. Data are mean (± s.d.) of 3 replicate wells within one
experiment. **, p=0.001.
(TIF)
Figure S3.  TEM image showing differentiated Caco-2 cells
incubated at 37° C for 3 h with (A) non-supplemented
control media (i.e. balanced salt solution, BSS), (B) control
BSS supplemented with maltol alone and (C) BSS
supplemented with 500 µM Fe as the soluble Fe(III) maltol
chelate. Scale bar, 500 nm.
(TIF)
Figure S4.  Effect of monensin on cellular protein levels in
Caco-2 monolayers. Cells were incubated for 1 h in BSS
supplemented with different concentrations of monensin plus a
further 23 h in fresh, non-supplemented MEM. Box and whisker
plots show median, minimum and maximum for n=6
independent experiments. The red solid line represents the
mean cellular protein for all experiments and the dotted red
lines represent the corresponding 95% confidence interval. No
statistical differences were found for any monensin
concentration in relation to control cells incubated without
monensin (0 µM).
(TIF)
Figure S5.  Effect of siRNA targeting of DMT1 (closed bars)
and Dcyt B (open bars) on iron uptake in HuTu cells. HuTu
cells were transfected with siRNAs and, after 3 days, the cells
were incubated for 1 h in BSS supplemented with 10 µM Fe as
soluble Fe(II) (ferrous sulphate) or LM Fe(III) poly oxo-
hydroxide (nano Fe) plus a further 23 h in fresh, non-
supplemented MEM to allow for ferritin formation. Pattern bars
indicate scrambled-transfected cells. Data are mean (± s.d.) of
3 replicate wells within one experiment. ****, p<0.0001.
(TIF)
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